Institutional shares held 410 Million
1.02M calls
1.09M puts
Total value of holdings $67.9B
$168M calls
$181M puts
Market Cap $77.5B
468,139,008 Shares Out.
Institutional ownership 87.58%
# of Institutions 1,957


Latest Institutional Activity in ZTS

Top Purchases

Q3 2024
Ninety One Uk LTD Shares Held: 1.68M ($278M)
Q3 2024
International Assets Investment Management, LLC Shares Held: 940K ($156M)
Q3 2024
Holocene Advisors, LP Shares Held: 567K ($93.9M)
Q3 2024
Alliancebernstein L.P. Shares Held: 15.4M ($2.55B)
Q3 2024
Invesco Ltd. Shares Held: 2.39M ($396M)

Top Sells

Q3 2024
Wellington Management Group LLP Shares Held: 3.9M ($645M)
Q3 2024
Mizuho Securities Usa LLC Shares Held: 29.4K ($4.86M)
Q3 2024
Morgan Stanley Shares Held: 12M ($1.99B)
Q3 2024
Bank Of America Corp Shares Held: 14.4M ($2.38B)
Q3 2024
Polen Capital Management LLC Shares Held: 6.37M ($1.05B)

About ZTS

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.


Insider Transactions at ZTS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
126K Shares
From 20 Insiders
Exercise of conversion of derivative security 126K shares
Sell / Disposition
88.6K Shares
From 23 Insiders
Other acquisition or disposition 3.97K shares
Bona fide gift 19.1K shares
Payment of exercise price or tax liability 40.8K shares
Open market or private sale 24.8K shares

Track Institutional and Insider Activities on ZTS

Follow Zoetis Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZTS shares.

Notify only if

Insider Trading

Get notified when an Zoetis Inc. insider buys or sells ZTS shares.

Notify only if

News

Receive news related to Zoetis Inc.

Track Activities on ZTS